Intersolar Europe: Agrivoltaics – Harvesting Solar Power
27.4.2023 13:21:00 EEST | Business Wire | Press release
The world population is growing, as is the demand for food. To tackle the climate crisis, the world needs both agricultural land and surfaces for the deployment of photovoltaics (PV). In line with the zeitgeist, agricultural PV brings together both worlds: agriculture and renewable power generation. Solar modules built over fields can transport us into the new energy world faster, all the while protecting important agricultural yields. This is why Intersolar Europe – The world’s leading exhibition for the solar industry – will be focusing on the topic. Together with the French-German Office for Energy Transition (DFBEW), Intersolar Europe will be presenting new business models and best practices from France and Germany. Agricultural PV is also on the agenda of the Intersolar Europe Conference. Intersolar Europe will be held as part of The smarter E Europe, the continent’s largest platform for the energy industry, from June 14 to 16, 2023 in Munich.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230427005413/en/
Trend topic Agrivoltaics will be presented at Intersolar Europe 2023 in Munich, Germany. (Photo: Solar Promotion GmbH)
Agrivoltaics is currently trending. Agrivoltaics projects are demonstrating how the generation of solar power and agriculture can go hand in hand and benefit from each other and how the conflict over available surfaces can be cleverly solved.
Renewable electricity for decentralized self-consumption is a great opportunity for agricultural operations adding solar installations to their assets. It allows them to use the renewable power generated on their land and reduce their bills for grid-supplied electricity. If they have excess electricity, they can sell it, which provides an additional source of income. What’s more, agricultural PV installations can boost resilience and increase the yield of agricultural operations because solar modules offer protection against heavy rain, hail or drought for fruit and special crops.
Europe recognizes potential
In many European countries, more and more farmers and political decision-makers are recognizing the potential of agricultural PV. Italy, for instance, recently passed new regulations that determine which agricultural PV installations are eligible for funding from a government incentive program with a scope of 1.1 billion euros, giving a boost to innovative agricultural PV installations. While Germany is testing agricultural PV in combination with the cultivation of apples, for example, in Gelsdorf in Rhineland Palatinate, France has started installing solar modules over rows of vines.
With tractor and tracker – trend towards dual use
Covering crops with raised solar modules – as French winegrowers are doing now – is particularly interesting because it is favorable for winegrowing, as well as for fruit, berries or herbs, and any plants that prefer partial shade. Furthermore, solar roofs can replace conventional hail netting or polytunnels, and they protect the crops from drying out.
Integrating solar installations into agriculture opens up many areas of application. Free-standing solar installations on fields and meadows can also be equipped with trackers that follow the course of the sun, which increases the yield compared with conventional, fixed modules, by around 20 percent. The solar panels can also be moved out of the way of any working agricultural machinery.
Agri PV: Hot topic at Intersolar Europe
To learn all there is to know about solar power generation in agriculture, join us at Intersolar Europe. The session “Agricultural PV in France and Germany: Potential, Business Models and Best Practice” (Agri-PV in Deutschland und Frankreich: Potenziale, Geschäftsmodelle und Best Practices) on June 15 at 3:20pm CEST at the Intersolar Forum will be presenting an extensive overview of solutions and applications that already work. An even more hands-on experience will be offered by many exhibitors, such as BayWa r.e. AG, Fraunhofer Institute for Solar Energy Systems (ISE), Next2Sun GmbH, Goldbeck Solar GmbH, SunFarming GmbH and many more. The program of the Intersolar Europe Conference will be looking into agricultural PV one day before the start of the exhibition itself. Experts will be discussing the potential of solar power in agriculture.
Intersolar Europe will be held from June 14–16, 2023 as part of The smarter E Europe 2023 at Messe München. Over 85,000 visitors from all corners of the globe are expected to attend. More than 2,200 exhibitors across 17 exhibition halls covering 180,000 square meters will be waiting for them.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230427005413/en/
Contact information
Peggy Zilay
Spokesperson
The smarter E Europe
+49 7231 58598-240
zilay@solarpromotion.com
Juliane Heermeier
Account Manager
+49 151 41482446
juliane.heermeier@fischerappelt.de
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release
Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
